1. A phase II trial of low-dose estradiol in postmenopausal women with advanced breast cancer and acquired resistance to aromatase inhibition. Issue 18 (December 2015) Authors: Zucchini, G.; Armstrong, A.C.; Wardley, A.M.; Wilson, G.; Misra, V.; Seif, M.; Ryder, W.D.; Cope, J.; Blowers, E.; Howell, A.; Palmieri, C.; Howell, S.J. Journal: European journal of cancer Issue: Volume 51:Issue 18(2015:Dec.) Page Start: 2725 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Phase I trial of the MEK inhibitor selumetinib in combination with thoracic radiotherapy in non-small cell lung cancer. (May 2021) Authors: Haslett, K.; Koh, P.; Hudson, A.; Ryder, W.D.; Falk, S.; Mullan, D.; Taylor, B.; Califano, R.; Blackhall, F.; Faivre-Finn, C. Journal: Clinical and translational radiation oncology Issue: Volume 28(2021) Page Start: 24 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗